Table 4.
Impact of the FT protocol on the process of care of the two patient groups.
| Measure | Pre-FT | FT | Effect Measures (95% CI) | p-Value |
|---|---|---|---|---|
| 59 patients | 122 patients | |||
| Tourniquet time, median (Q1–Q3), minutes | 61 (54–69.5) | 35 (30–41) | <0.01 # | |
| Surgery time, median (Q1–Q3), minutes | 106 (94–115) | 86 (77–92) | <0.01 # | |
| Bladder catheter, n (%) | 16 (27) | 10 (8) | 0.19 (0.08–0.43) $ | <0.01 |
| Surgical drain, n (%) | 54 (92) | 0 (0) | −0.92 (−0.99 to −0.84) * | <0.01 |
| Subarachnoidanesthesia, n (%) | 34 (57) | 6 (5) | −0.53 (−0.66 to −0.40) * | <0.01 |
| General anesthesia, n (%) | 17 (28) | 11 (10) | −0.20 (−0.32 to −0.07) * | <0.01 |
| Combined anesthesia, n (%) | 9 (15) | 104 (85) | 0.70 (0.59 to 0.81) * | <0.01 |
Legend: CI, confidence interval; FT, fast-track; Q1, first quartile; Q3, third quartile; # Mann–Whitney U test; $ adjusted odds ratio; * crude risk difference. Combined anesthesia was defined as selective subarachnoid anesthesia and short-acting sedative hypnotic agents.